Register
.
CSI 2017

Kolkata,  30 November 2017 -03 December 2017


Conferences
Choice of Antihypertensive Therapy in Young Individuals: Are there any Differences from the Usual Practice?
Dr HK Chopra, New Delhi, 13 December 2017
#Cardiology #Nephrology
Individualize your patient and create your own protocol ...MORE
535 Views
0 Comments

Conferences
Statins in Primary and Secondary Prevention of CAD Are they fully utilized?
Dr K Jai Shankar, Chennai, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Primary prevention refers to delaying or preventing the onset of CVD. Secondary prevention relies on early detection of disease process and application of inter ...MORE
518 Views
1 Comments

Conferences
When should I Ask for ABPM in My Hypertensive Patient Who is Already on Treatment?
Dr Anjan Lal Dutta, Kolkata, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Ambulatory BP monitoring is done for: White-coat HT; masked HT; early morning surge of BP; suspected episode of HT; patients with high risk CV events, even if c ...MORE
524 Views
0 Comments

Conferences
Clinical Dilemmas in Lipid Management
Dr Prakash Deedwania, USA, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Diabetes is a vascular disease and most patients with diabetes die from CV complications. Diabetes is associated with 2- to 4-fold increase in the risk of MI, s ...MORE
490 Views
0 Comments

Conferences
Assessment of Severity of Valvular Regurgitations 3D Echo Solves All My Problems
Prof Dr V Amuthan, Madurai, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Echo is the imaging modality of choice for imaging in valvular heart disease. Real time 3D echo has revolutionized assessment of mitral valve pathology and pati ...MORE
578 Views
0 Comments

Conferences
Drugs that I can’t Avoid Knowing About: Canagliflozin
Dr Dharmendra Jain, Varanasi, 19 December 2017
#Cardiology #Diabetes and Endocrinology
The uniqueness of SGLT2 inhibition is the β-cell independent mechanism of action. Regarding CV risk factor reduction, canagliflozin is now confirmed to be ...MORE
495 Views
0 Comments

Conferences
LDL-C Level <40 mg/dL: Is It Harmful?
Dr Ananda Bagchi, Kolkata, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Every incremental LDL-C level is associated with significant increase in the risk of ASCVD. The potential risk of lowering LDL-C to very low levels (<40 mg/d ...MORE
532 Views
0 Comments

Conferences
ARNi (LCZ696): Angiotensin Receptor Neprilysin Inhibitor
Dr Anil Bharani, Indore, 19 December 2017
#Cardiology #Diabetes and Endocrinology
ARNi is a novel drug, first in class, which delivers simultaneous neprilysin inhibition and AT1 receptor blockade. It is indicated to reduce the risk of CV deat ...MORE
496 Views
0 Comments

Conferences
Cardiac MRI
Dr Vimal Raj, Bengaluru, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Cardiac magnetic resonance (CMR) imaging is a one-stop shop for all cardiac problems. It is the gold standard for LV and RV functional assessment. The high spat ...MORE
462 Views
0 Comments

Conferences
Ultrathin Bioabsorbable Polymer DES: New Benchmark in the Field of DES
Dr Thomas Pilgrim, Switzerland, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Ultrathin strut biodegradable polymer sirolimus-eluting stents (Orsiro) are noninferior to newer generation DES with durable polymers (Xience, Resolute) with re ...MORE
635 Views
0 Comments

Conferences
Transradial Angioplasty Trumps Failed CABG with Successful CTO Revascularization
Dr Sanjay Chugh, Jaipur, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Complex angioplasty can be done successfully transradially, which is more comfortable for patients because it allows early mobilization and also saves more live ...MORE
561 Views
0 Comments

Conferences
2D Strain in Valvular Heart Disease: Ready for Prime Time?
Dr Satish C Govind, Bengaluru, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Role of 2D strain in echocardiography of valvular heart disease has gained lot of attention over the last few years. Global longitudinal strain (GLS), a robust ...MORE
640 Views
0 Comments

Conferences
Functional MR in Ischemic LV Dysfunction Challenging to Assess and Even More Challenging to Treat
Dr Niteen V Deshpande, Nagpur, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Secondary (functional) MR in patients with ischemic LV dysfunction is a marker of poorer prognosis. It is important to assess mechanism contributing to MR, whic ...MORE
586 Views
0 Comments

Conferences
Myocardial Viability by MRI
Dr Johann Christopher, Hyderabad, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Myocardial viability assessment is essential prior to revascularization of dysfunctional myocardium. Myocardial viability can be assessed by multiple techniques ...MORE
595 Views
0 Comments

Conferences
CTO: Tips & Tricks
Dr AB Mehta, Mumbai, 19 December 2017
#Cardiology #Diabetes and Endocrinology
CTO is encountered in 10-15% of all the cases who undergo coronary angiography for coronary disease. Till about a decade ago, it was the second commonest cause ...MORE
611 Views
0 Comments

Conferences
6MWT in Heart Failure
Dr KK Aggarwal, Group Editor-in-Chief IJCP Group, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Exercise intolerance, along with dyspnea, fatigue are cardinal symptoms of heart failure (HF), which adversely impact quality-of-life (QoL) of the patient. Exer ...MORE
638 Views
0 Comments

Conferences
Case Which Stunned Me in 2017!
Dr Vivek Tandon, New Delhi, Dr Sunil Bohra Bengaluru, 19 December 2017
#Cardiology #Diabetes and Endocrinology
A patient who had suffered an anterior MI, and had PTCA and stent to mid LAD, was referred for a predischarge echo, which showed wall motion abnormality in LAD ...MORE
650 Views
0 Comments

Conferences
Atrial Flutter: A Different Arrhythmia from Atrial Fibrillation
Dr Samuel J Asirvatham, USA, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Atrial flutter and fibrillation tend to co-exist in the same patient. However, the electrophysiological mechanisms and approach to treatment are very different. ...MORE
461 Views
0 Comments

Conferences
Apical Dilatation of Left Ventricle
Dr Aniruddha De, Kolkata, 19 December 2017
#Cardiology #Diabetes and Endocrinology
A 9-year-old boy presented with cyanosis, clubbing, shortness of breath (Class III) and mild hepatomegaly.Echo showed large apical VSD with separation of RV ape ...MORE
555 Views
0 Comments

Conferences
Does Reducing LDL to Ultra-low Level (<25 mg/dL) have Additional Benefit on CVD Events or Safety Concerns?
Dr AK Pancholia, Indore, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Patients achieving very low LDL levels (<25 mg/dL) do not show any increase in clinical and lab side effects vs. those with higher LDL-C or control groups in ...MORE
600 Views
0 Comments

Conferences
From Histology to Physiology, CMR has all the Answers
Dr Mona Bhatia, New Delhi, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Cardiac MRI (CMR) with its high spatial and temporal resolution is excellent for ventricular morphology and functional assessment and is currently the gold stan ...MORE
613 Views
0 Comments

Conferences
Dyslipidemia in Young with LDL-C >190 mg/dL
Dr B Kesavamoorthy, Thanjavur, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Most patients with LDL >190 mg/dL have polygenic hypercholesterolemia. They are at a very high risk of first and recurrent ASCVD events because of lifetime e ...MORE
565 Views
0 Comments

Conferences
Native Coarctation in Adults: Balloon/Stent/Surgery?
Dr Sushil Azad, New Delhi, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Management of adult coarctation of aorta continues to evolve. Balloon angioplasty alone is associated with less favorable hemodynamic results with more incidenc ...MORE
646 Views
0 Comments

Conferences
Echocardiograhy in Tetralogy of Fallot
Dr Munesh Tomar, Haryana, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Tetralogy of Fallot (TOF) is a congenital cyanotic heart disease comprised of four anatomic features: Anterior malalignment of the infundibular septum leading t ...MORE
653 Views
0 Comments

Conferences
A Disciplined Approach to Hypertension Management
Dr Saroj Mondal, Kolkata, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Treating hypertension reduces the risk of cardiovascular disease (CVD) outcomes. Systolic BP targets to reduce CV morbidity and mortality among persons without ...MORE
518 Views
0 Comments

Conferences
Know Your Drug: Azilsartan
Dr Sudeep Kumar, Lucknow, 19 December 2017
#Cardiology #Diabetes and Endocrinology
As a potent ARB, azilsartan offers greater BP reduction (in mmHg); greater response rate/target BP goal achievement; consistent and larger magnitude of BP reduc ...MORE
479 Views
0 Comments

Conferences
Circadian Rhythm and Timing of Antihypertensive Drugs Any Relevance?
Dr Mrinal Kanti Das, Kolkata, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Concept of circadian variation of BP has entered the clinical domain in 21st century. BP is highest in early to mid-morning and falls progressively all through ...MORE
649 Views
0 Comments

Conferences
ABCD of Pharmacological Therapy in Heart Failure
Dr VK Chopra, Gurugram, 19 December 2017
#Cardiology #Diabetes and Endocrinology
ACEI/ARBs/ARNI and β blockers are neurohormonal modulators and should be used in all HFrEF patients unless contraindicated, as they have been shown to redu ...MORE
511 Views
0 Comments

Conferences
RVOT Obstruction by Mediastinal Mass
Dr Aniruddha De, Kolkata, 19 December 2017
#Cardiology #Diabetes and Endocrinology
A 23-year-old lady presented with generalized weakness, easy fatigability and dyspnea on exertion for last few months. Pulse was 86/min, BP 110/70 mmHg, soft ej ...MORE
493 Views
0 Comments

Conferences
Role of IV Iron Beyond Anemia and Hemoglobin in Heart Failure
Dr Prasant Kr Sahoo, Bhubaneswar, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Iron plays an important role in cell metabolism throughout the body. Iron is a metabolically active micronutrient with a multitude of effects on the body’ ...MORE
664 Views
0 Comments

Conferences
Percutaneous Mitral Valve in Valve Procedure for Failing Mitral Bioprosthetic Valve
Dr Nagendra S Chouhan, Gurugram, 19 December 2017
#Cardiology #Diabetes and Endocrinology
‹‹ Bioprostetic valve failure rates are significantly high, after 10 years of implant and reoperations.‹‹ It has poor outcome in high risk e ...MORE
502 Views
0 Comments

Conferences
Ablative Therapy in ARVD and Brugada Syndrome: Is There a role?
Dr Daljeet Kaur Saggu, Hyderabad, 19 December 2017
#Cardiology #Diabetes and Endocrinology
‹‹ Catheter ablation is feasible in patients with both ARVD and Brugada syndrome, who have recurrent ICD shocks secondary to refractory VT.‹‹ ...MORE
547 Views
0 Comments

Conferences
Managing Resistant HT: What Options Do I have When Drugs Fail?
Dr Keshavamurthy V, Mysore, 19 December 2017
#Cardiology #Diabetes and Endocrinology
‹‹ Resistant HT is a common problem in a subset of patients.‹‹ Pseudoresistance needs to be ruled out.‹‹ ABPM is a very helpful to ...MORE
687 Views
0 Comments

Conferences
Visceral Fat Estimation for CAD Risk
Dr AK Chauhan Bareilly, UP, 19 December 2017
#Cardiology #Diabetes and Endocrinology
CVD is a leading cause of mortality globally. The prevalence of obesity and diabetes is on the rise.Visceral fat enhancement is more prevalent and is associated ...MORE
679 Views
0 Comments

Conferences
Endovascular Management of Abdominal Aortic Aneurysms Recent Triumph & Unconquered Territories
Dr NN Khanna, New Delhi, 19 December 2017
#Cardiology #Diabetes and Endocrinology
More than 35,000 deaths per year are directly attributed to aortic aneurysm (AA), which is the 9th leading cause of death. The risk of rupture in AA increases w ...MORE
588 Views
0 Comments

Conferences
Does Device-detected AF Cause Strokes?
Dr Alan Cheng, USA, 19 December 2017
#Cardiology #Diabetes and Endocrinology
‹‹ The epidemiology of AF is different in India compared to the rest of the world.‹‹ AF is strongly associated with an increased risk for st ...MORE
560 Views
0 Comments

Conferences
Paroxysmal AF Ablation: My Targets and Endpoints
Dr Samuel J Asirvatham, USA, 19 December 2017
#Cardiology #Diabetes and Endocrinology
‹‹ Atrial fibrillation ablation remains an excellent palliative therapy for symptomatic patients with this rhythm disorder. Yet, severe complications ...MORE
486 Views
0 Comments

Conferences
Clinical Dilemmas in Lipid Management
Dr Pamela Morris, USA, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Case: A 62-year-old diabetic, underwent CABG-6 weeks back, has LDL 124 mg/dl, TG 178 mg/dl; develops significant myalgia with even  20 mg/dL atorvastatin. ...MORE
528 Views
0 Comments

Conferences
PISA for Evaluation of Regurgitant Lesions
Dr Vivek Tandon, New Delhi, 19 December 2017
#Cardiology #Diabetes and Endocrinology
Proximal isovelocity surface area (PISA) has become one of the most useful tools for quantitative and qualitative assessment of regurgitant valvular lesions, es ...MORE
469 Views
0 Comments

Conferences
Do All Patients Needing CRT-P Require CRT-D?
Dr Nitish Naik, New Delhi, 19 December 2017
#Cardiology #Diabetes and Endocrinology
CRT has been shown to improve survival in patients with LV dysfunction, LBBB and in ischemic cardiomyopathy. However, benefit of defibrillator in DCM is less cl ...MORE
483 Views
0 Comments

Conferences
Advanced Therapy in Advanced Heart Failure
Dr Mandeep R Mehra, USA, 19 December 2017
#Cardiology #Diabetes and Endocrinology
“Success is not final, failure is not fatal; it is the courage to continue that counts”.—Winston ChurchillThere has been a paradigm change in ...MORE
661 Views
0 Comments

Conferences
AF in a Patient with HT: Clinical Dilemmas and Evidence-based Management
Dr Paolo Verdecchia, Italy, 19 December 2017
#Cardiology #Diabetes and Endocrinology
‹‹ Studies suggest that a more intensive BP control (systolic BP target <130 or <120 mmHg) in hypertensive patients who are in sinus rhythm coul ...MORE
583 Views
0 Comments

Conferences
RV Septal Pacing: Should We Go for It?
Dr John Roshan Jacob ,Vellore, 19 December 2017
#Cardiology #Diabetes and Endocrinology
‹‹ RV apical pacing is definitely substandard. It is associated with electromechanical dyssynchrony which, over time, can cause ventriculardysfunction ...MORE
467 Views
0 Comments

Conferences
Live-in-box Cases: LMCA
Dr Seung-Woon Rha, Korea, 19 December 2017
#Cardiology #Diabetes and Endocrinology
‹‹ How to overcome very angulated lesion? Single wire with Sion blue/ Sion black, Reverse wire technique and Double lumen microcatheter.‹&l ...MORE
516 Views
0 Comments

Conferences
Yoga: A Promising Technique to Control CVD
Dr SC Manchanda, New Delhi, 04 January 2018
#Cardiology
Cardiovascular diseases attribute to almost 31% of global deaths.There are strong evidences to show the role of yoga in reducing stress with improvement in both ...MORE
520 Views
0 Comments

Conferences
Selecting Antidiabetic Drugs in a Patient with CAD
Dr Shashank R Joshi, Mumbai, 04 January 2018
#Cardiology #Diabetes and Endocrinology
Indians have low metabolic tolerance, known as ‘thin-fat’ Indian phenotype. Hence, weight loss is of importance in Indian patients with type 2 diabe ...MORE
462 Views
0 Comments

Conferences
Quality and Safety of Acute Cardiovascular Care in India
Dr PP Mohanan, Thrissur, 04 January 2018
#Cardiology
As per the National Academy of Medicine (US), quality is defined as the “degree to which health services for individuals and populations increase the likelihood ...MORE
426 Views
0 Comments

Conferences
Developing an Appropriate STEMI System of Care in India The STEMI India Model
Dr Thomas Alexander, Coimbatore, 04 January 2018
#Cardiology #Public Health
The STEMI India model for STEMI management combines the two reperfusion strategies of primary PCI and pharmacoinvasive treatment to build a hub and spoke model. ...MORE
508 Views
0 Comments

Conferences
LDL is Only Half Truth; Non-HDL-C is the Real Thing
Dr SN Narasingan, Chennai, 04 January 2018
#Cardiology
Despite marked ASCVD risk reduction, residual risk of ASCVD in statin-treated patients remains as high as 55-70%. Hence, we need to concentrate on all atherogen ...MORE
467 Views
0 Comments

Conferences
SAVR vs. TAVR
Dr OP Yadava, New Delhi, 04 January 2018
#Cardiology
TAVR is a welcome development, and is a big boon for a large number of patients with clinically significant aortic valve pathologies, which are deemed prohibiti ...MORE
518 Views
0 Comments

Conferences
Preoperative Rosuvastatin Protects Patients with Coronary Artery Disease Undergoing Noncardiac Surgery
Dr Dilip Kumar, Kolkata, 04 January 2018
#Cardiology #General Surgery
The prevalence of cardiovascular disease (CVD) increases with age, as does the need for emergency surgical intervention in a variety of other health conditions. ...MORE
564 Views
0 Comments

Conferences
Coronary Myocardial Bridge: A Long-term Follow-up Study
Dr Chandan Kumar Das, Bilaspur, 04 January 2018
#Cardiology #Diabetes and Endocrinology
CAD has taken the shape of epidemic in India, particularly in the young population today. ...MORE
438 Views
0 Comments

Conferences
Treating HFpEF: Huff-Puff without a Solution?
Dr PB Jayagopal, Palakkad, 04 January 2018
#Cardiology
HFpEF is prevalent mostly in elderly with multiple comorbid conditions. ...MORE
546 Views
0 Comments

Conferences
Scar VT Ablation: Substrate-based Ablation or Entrainment Mapping of VTs?
Dr Samuel J Asirvatham, USA, 04 January 2018
#Cardiology
Although ICDs have clearly been documented to improve lifespan in patients with structural heart disease and ventricular tachycardia (VT), frequent shocks remai ...MORE
547 Views
0 Comments

Conferences
STEMI Care for All in UAE
Dr Brajesh Mittal, UAE, 04 January 2018
#Cardiology
Death rates from cardiovascular diseases is more than double of that in the western countries. ...MORE
581 Views
0 Comments

Conferences
Myocardial Reperfusion Injury
Dr Ramesh Daggubati, USA, 04 January 2018
#Cardiology
Myocardial reperfusion injury can present in patients as stunning, no-reflow, arrhythmias or lethal reperfusion injury after opening an occluded artery during S ...MORE
495 Views
0 Comments

Conferences
Renal Dysfunction in HF: A Catch 22 Situation
Dr I Sathyamurthy, Chennai, 04 January 2018
#Cardiology
HF patients are prone to renal dysfunction due to interplay between heart and kidney. Type I and II CRS are secondary to HF. The incidence varies from 20% to 30 ...MORE
457 Views
0 Comments

Conferences
A Novel Risk Factor for Heart Failure
Prof UC Samal, Patna, 04 January 2018
#Cardiology
Dietary-associated and intestinal microbiota-dependent metabolite TMAO has emerged as an independent CV risk factor. TMAO is a toxic end product in our food con ...MORE
612 Views
0 Comments

Conferences
OCT: Technique and Image Interpretation
Dr G Sengottuvelu, Chennai, 04 January 2018
#Cardiology
OCT started as a research tool, but now is graduating to become an important clinical tool particularly to view the endoluminal structure of the blood vessels. ...MORE
552 Views
0 Comments

Conferences
Acute Myocarditis with HF: Role of Pharmacotherapy
Prof Dr Amal Kumar Choudhury, Bangladesh, 04 January 2018
#Cardiology #Cardiology
Myocarditis is a gray zone. ...MORE
577 Views
0 Comments

Conferences
Alternate Day Iron Supplementation Preferred to Daily Dosing in iron Deficiency
Dr KK Aggarwal, Group Editor-in-Chief IJCP Group, 04 January 2018
#Cardiology
Anemia in patients with heart failure is common. Several factors including iron deficiency, hemodilution, ACEIs, renal insufficiency, poor nutrition may contrib ...MORE
618 Views
0 Comments

Conferences
Improving Survival Rates Among Heart Failure Patients with the Use of Novel Drugs
Dr PK Hazra, Kolkata, 04 January 2018
#Cardiology #Cardiology
Heart failure is an important global health problem, affecting about 26 million people worldwide.1 In India, cardiovascular diseases like heart failure and card ...MORE
451 Views
0 Comments

Conferences
CAD - Different Strokes A 52-year-old diabetic presents with chest pain with transient ST elevation on ECG; coronary angiography shows minor plaques
Prof Naveen Garg, Lucknow, 04 January 2018
#Cardiology #Diabetes and Endocrinology
About 5% patients can have acute myocardial infarction (AMI) with normal coronaries (or mild plaquing). Atherosclerotic CAD is still the commonest cause. ...MORE
590 Views
0 Comments

Conferences
Tackling AF in Patients Undergoing Surgery for Valvular Heart Disease
Dr Anil Patwardhan, Mumbai, 04 January 2018
#Cardiology #General Surgery
"Ablate we must, tools may vary”STS 2017 Clinical Practice Guidelines: Surgical ablation for AF can be performed without additional risk of operative mort ...MORE
563 Views
0 Comments

Conferences
Major Trials with Major Impact: Compass Trial
Dr Pankaj Jariwala, Hyderabad, 04 January 2018
#Cardiology
Rivaroxaban 2.5 mg b.i.d. + aspirin 100 mg o.d.: Reduces CV death, stroke, MI; increases major bleeding without a significant increase in fatal, intracranial or ...MORE
579 Views
0 Comments

Conferences
Current Concepts in Right Heart Failure
Dr Mandeep Mehra, USA, 04 January 2018
#Cardiology
Right heart failure is defined as a clinical syndrome due to an alteration of structure and/or function of the right heart system that leads to suboptimal deliv ...MORE
497 Views
0 Comments

Conferences
Severe Triple Vessel Disease in a Patient with LVEF 20%
Dr Y Vijayachandra Reddy, Chennai, 04 January 2018
#Cardiology #Diabetes and Endocrinology
This is a very high-risk group of CAD but should not be dubbed as “No-Option group” without proper workup. ...MORE
601 Views
0 Comments

Conferences
Bariatric Surgery for Prevention of CVD and Diabetes
Dr Surendra Ugale, Hyderabad, 04 January 2018
#Cardiology #Diabetes and Endocrinology
Obesity is associated with increased total and CV mortality due to accelerated atherosclerosis. ...MORE
610 Views
0 Comments

Conferences
PH-directed Therapy in COPD
Prof MN Krishnan, Calicut, 04 January 2018
#Cardiology #Pulmonary Medicine
Routing treatment of COPD with pulmonary hypertension (PH) reducing drugs is controversial. ...MORE
593 Views
0 Comments

Conferences
Updated Assessment and Treatment of Diabetes with Hypertension
Dr Rajiv Agarwal, New Delhi, 04 January 2018
#Cardiology #Diabetes and Endocrinology
Hypertension is common among patients with diabetes. More than 60% of T2DM have hypertension. There is evidence that ASCVD morbidity and mortality have decrease ...MORE
486 Views
0 Comments

Conferences
Diagnosing HFpEF: Can We Simplify It?
Dr Partho P Sengupta, USA, 04 January 2018
#Cardiology #Diabetes and Endocrinology
HFpEF is a complex heterogeneous disorder. ...MORE
649 Views
0 Comments

Conferences
Explaining CVD Epidemic in Urbanized South Asians Worldwide A New Causal Synthesis
Prof Raj Bhopal, Scotland, 04 January 2018
#Cardiology #Diabetes and Endocrinology
Indians in urbanized environments, in common with other South Asians, are at unusually high risk of coronary heart disease (and type 2 diabetes). ...MORE
601 Views
0 Comments

Conferences
IV Iron Therapy in HF: Is it Ready for Implementation?
Dr Dharmendra Jain, Varanasi, 04 January 2018
#Cardiology
Iron deficiency is a prevalent and clinically relevant comorbidity in up to 50% of patients with chronic heart failure (CHF). Iron deficiency in CHF patients is ...MORE
579 Views
0 Comments

Conferences
Physical Activity for CVD Prevention: Evidence-based Recommendations
Dr Charan P Lanjewar, Mumbai, 04 January 2018
#Cardiology
CVD is preventable.Consider physical activity for CVD prevention as well as treatment.Regular physical activity decreases all-cause mortality and CVD mortality. ...MORE
609 Views
0 Comments

Conferences
Rheumatic Mitral Repair: Replacement is not the Only Option
Dr Amit Chandra, Gurugram, 04 January 2018
#Cardiology
Majority of rheumatic mitral valves in our country are replaced because the durability of rheumatic mitral repair (in terms of freedom from re-operation) is inf ...MORE
591 Views
0 Comments

Conferences
When and How to Look for CVD in Asymptomatic Diabetic Patients?
Dr Dayasagar Rao V, Hyderabad, 04 January 2018
#Cardiology #Diabetes and Endocrinology
Nearly 65% deaths in patients with diabetics are due to CVD (CAD/CVA/HF). ...MORE
487 Views
0 Comments

Conferences
Pulmonary HT: Case-based Management Options A 66-year-old gentleman with severe COPD with PASP 66 mmHg and right HF
Dr Suvro Banerjee, Kolkata, 04 January 2018
#Cardiology
Severe pulmonary hypertension is uncommon in COPD. If severe pulmonary hypertension is present in a patient with COPD, other associated causes such as left hear ...MORE
504 Views
0 Comments

Conferences
Pulmonary Hypertension
Dr Rahul Mehrotra, New Delhi, 04 January 2018
#Cardiology #Pulmonary Medicine
Systematic evaluation of a patient of dyspnea is paramount for early diagnosis of pulmonary hypertension. ...MORE
580 Views
0 Comments

Conferences
Prevention of CVD - From Epidemiology to Guidelines and Policies Guidelines for Treatment of Blood Cholesterol to Reduce ASCVD Risk in Adults: Contributions, Confusions and Consensus
Dr Pamela Morris, USA, 04 January 2018
#Cardiology #Diabetes and Endocrinology
The ASCVD prevention guidelines are in agreement about healthy lifestyles as foundations for the prevention of ASCVD; LDL-related ASCVD risk is important; inten ...MORE
430 Views
0 Comments

Conferences
Partnerships for Public Purpose
Dr D Prabhakaran, Gurugram, 04 January 2018
#Cardiology #Diabetes and Endocrinology
Center for Chronic Conditions and Injuries (CCCI) is involved in various activities including epidemiological and basic research; translational research and imp ...MORE
624 Views
0 Comments

Conferences
Advances in the Management of HFrEF Rationale for the Use of Neprilysin Inhibitors
Dr Inder S Anand, USA, 04 January 2018
#Cardiology
Despite remarkable improvement in the outcomes of patients with heart failure with reduced ejection fraction (HFrEF), using evidence-based pharmacological and d ...MORE
543 Views
0 Comments

Conferences
Advances in HF Management: From Diagnostics to Therapeutics Echo for Prognosis in HF
Dr John Gorcsan, USA, 04 January 2018
#Cardiology
A comprehensive echo Doppler examination adds prognostic information. ...MORE
574 Views
0 Comments

Conferences
Hemodynamic Support in LM Intervention
Dr Seung-Woon Rha, Korea, 04 January 2018
#Cardiology
How to prepare and prevent hemodynamic instability during complex LM intervention? Inotropes and prophylactic IABP. ...MORE
473 Views
0 Comments

Conferences
Apt-ness of Evaluation and Therapy in Clinical Practice
Dr Shirish (MS) Hiremath, Pune, 05 January 2018
#Cardiology
According to Dr Spencer B King, Editor-in-chief, JACC: Cardiovascular Intervention; “appropriateness criteria are intended to assist patients and clinicians but ...MORE
548 Views
0 Comments

Conferences
Latest 2017 Hypertension Guidelines
Dr C Venkata S Ram, Australia, 05 January 2018
#Cardiology
The new definition of HT given by AHA/ACC is BP greater than 130/80 mmHg. ...MORE
492 Views
0 Comments

Conferences
Changing Indications of TAVR
Dr Ashok Seth, New Delhi, 05 January 2018
#Cardiology
Expanding indications for TAVR: Intermediate to low risk patients, bicuspid aortic valve, degenerating surgical bioprosthetic valves and AR. ...MORE
558 Views
0 Comments

Conferences
NSTEMI ACS Management
Prof Dr Saumitra Ray, Kolkata, 05 January 2018
#Cardiology
All NSTEMI ACS are not the same. ...MORE
440 Views
0 Comments

Conferences
ACEI remains the Gold Standard
Dr PK Deb, Kolkata, 05 January 2018
#Cardiology
ARB was introduced in 1990 for treatment of HT and subsequently used for HFrEF. ...MORE
581 Views
0 Comments

Conferences
CSI Position Statement on Management of HF in India 2017
Dr Santanu Guha, Kolkata, 05 January 2018
#Cardiology #Diabetes and Endocrinology
HF presents about a decade earlier in India, most of the burden is <65 years. ...MORE
554 Views
0 Comments

Conferences
Whats Trending in the Management of HF in 2017?
Dr Ramachandra Barik, Hyderabad, 05 January 2018
#Cardiology #Diabetes and Endocrinology
The burden of heart failure (HF) in India appears to be high. A conservative estimation of the prevalence of HF in India due to CHD, HT, obesity, diabetes and r ...MORE
619 Views
0 Comments

Conferences
ARNI as First-line Therapy in the Management of Heart Failure
Dr Bhagirath Raghuraman, Bengaluru, 05 January 2018
#Cardiology
Augmentation of the natriuretic peptide systems is a novel approach in the management of HF and a new paradigm in neurohormonal modulation for HFrEF. ...MORE
495 Views
0 Comments

Conferences
HCM: Epidemiology, Genetics and Risk Stratification
Dr Ajay Bahl, Chandigarh, 05 January 2018
#Cardiology
Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac disorder caused by mutations in cardiac sarcomeric genes. ...MORE
613 Views
0 Comments

Conferences
Management Issues in Patients Requiring Antiplatelets and Anticoagulation A 74-year-old diabetic gentleman with fracture hip and positive dobutamine stress echo
Dr Suresh K, Trivandrum, 05 January 2018
#Cardiology #Diabetes and Endocrinology
Hip fracture obviously needs urgent or semiurgent hip surgery. ...MORE
552 Views
0 Comments

Conferences
PTCA or CABG in Diabetes Mellitus
Prof Sundeep Mishra, New Delhi, 05 January 2018
#Cardiology #Diabetes and Endocrinology
Several pathophysiological factors confer high risk after revascularization. ...MORE
642 Views
0 Comments

Conferences
How can we in India Adopt to these Latest Guidelines
Dr Gurpreet S Wander, Ludhiana, 05 January 2018
#Cardiology
The term ‘prehypertension’ used in JNC 7 was not adopted by anyone else and also in Indian guidelines. ...MORE
641 Views
0 Comments

Conferences
Never Declare a Patient Dead Under Conditions of Hypothermia
Dr KK Aggarwal, Group Editor-in-Chief IJCP Group, 06 January 2018
#Cardiology
A core body temperature below 95°F is hypothermia. Core temperature 90-95°F is mild hypothermia, 82-90°F is moderate hypothermia and core temperature below 82°F ...MORE
538 Views
0 Comments

Conferences
Digoxin in Heart Failure: Kabhi Haan, Kabhi Naa
Dr Nagaraj Desai, Mysuru, 06 January 2018
#Cardiology
Use of digoxin, in some contemporary clinical practices, is rapidly dwindling. ...MORE
483 Views
0 Comments

Conferences
Antiplatelets and Anticoagulants in NSTEMI Too Much Confusion: Which Ones should I Choose?
Dr Smit Shrivastava, Kanpur, 06 January 2018
#Cardiology
Aspirin is for all patients. Loading dose is 162-325 mg of uncoated aspirin; the first tablet should be chewed or crushed to establish a high blood level quickl ...MORE
581 Views
0 Comments

Conferences
Peripartum Cardiomyopathy: Changing Definition & Newer Therapies
Dr Asha Moorthy, Chennai, 06 January 2018
#Cardiology #Obstetrics and Gynecology
Definition of PCPM: Loose definition - Identify more Cases (ESC) ...MORE
566 Views
0 Comments

Conferences
Which NOAC for which Patient with Nonvalvular AF?
Dr Srinivasa Rao Maddury, Hyderabad, 06 January 2018
#Cardiology
In clinical trials, non-vitamin K antagonist oral anticoagulants (NOACs) have demonstrated favorable efficacy and safety profiles vs. vitamin K anatagonist (VKA ...MORE
583 Views
0 Comments

Conferences
Ongoing Dilemmas in RHD
Dr Vikas Singh, Patna, 06 January 2018
#Cardiology
Rheumatic heart diseases (RHDs), in spite of having seen a big decline even to the extent of near eradication in some developed countries, is still a major heal ...MORE
554 Views
0 Comments

Conferences
Remote Hemodynamic Monitoring in Ambulatory Heart Failure
Dr Joy M Thomas, Chennai, 06 January 2018
#Cardiology #Cardiology
Ambulatory HF patients constitute Heart Failure Groups I and II and Class A, B and C. They may be on conventional standard management, may have a device implant ...MORE
620 Views
0 Comments

Conferences
An Update on Hypertension Treatment
Dr PK Biswas, Kolkata, 06 January 2018
#Cardiology
High BP is the single largest risk factor for disease burden worldwide.1 ...MORE
428 Views
0 Comments

Conferences
Accurate Measurement of BP is the Key to Control HT
Dr BA Muruganathan, Tamil Nadu, 06 January 2018
#Cardiology
Accurate measurement of BP, as per protocol, is a must for correct diagnosis. ...MORE
590 Views
0 Comments

Conferences
PCSK9 Inhibitors as Add on to Statins Evidence Base for Current Clinical Utility
Prof Dr PC Manoria, Bhopal, 06 January 2018
#Cardiology
PCSK9 is a new validated target for lipid management. PCSK9 is an enzyme expressed in the liver and produces lysosomal degradation of LDL-C receptors, which are ...MORE
440 Views
0 Comments

Conferences
Surgical Options for HOCM
Dr Ganeshakrishnan Iyer, Bengaluru, 06 January 2018
#Cardiology
Septal myectomy is the gold standard, where expertise is available. ...MORE
507 Views
0 Comments

Conferences
IV Iron, Not Oral, Improves Functional Capacity in HF Patients
Dr Puneet Rastogi, Gwalior, 06 January 2018
#Cardiology
Last year, two new studies testing iron supplementation in patients with HF yielded opposite findings. ...MORE
595 Views
0 Comments

Conferences
Nuclear Imaging is Passé: CMR is the New Gold Standard
Dr Johann Christopher, Hyderabad, 06 January 2018
#Cardiology
Valvular regurgitation can be assessed by multiple imaging modalities. ...MORE
478 Views
0 Comments

Conferences
Cardiovascular Polypill: Rationale, Evidence and Progress to Date
Dr Mark Huffman, Chicago, 06 January 2018
#Cardiology
Rather than being a panacea for all, polypills represent the most effective and scalable intervention for improving adherence to multi-drug therapy for initiati ...MORE
586 Views
0 Comments

Conferences
Chemotherapy-induced Cardiac Dysfunction: How to Prevent It?
Prof Dr Geetha Subramanian, Varanasi, 06 January 2018
#Cardiology
Choose the less cardiotoxic drugs or the less cardiotoxic combinations (including radiotherapy). ...MORE
582 Views
0 Comments

Conferences
HDL and CVD Risk: The Current Understanding
Dr Akshay Mehta, Mumbai, 06 January 2018
#Cardiology #Diabetes and Endocrinology
Observational studies have shown an inverse relationship between the amount of HDL-C represented by its blood level and incidence of CHD. This finding (besides ...MORE
613 Views
0 Comments

Conferences
Controversies in Lipid Management
Dr Devendra Prasad Singh, Bhagalpur, 06 January 2018
#Cardiology #Diabetes and Endocrinology
For decades, statin therapy has been the cornerstone in the management of dyslipidemia. But numerous studies failed to demonstrate a mortality benefit in CVDs. ...MORE
562 Views
0 Comments

Conferences
Myocardial Involvement in Rheumatic Fever Does it Occur and What is its Relevance?
Prof A George Koshy, Trivandrum, 06 January 2018
#Cardiology
Traditionally, acute rheumatic fever (ARF) is known to produce pancarditis (endocarditis, myocarditis and pericarditis). Histopathological studies have demonstr ...MORE
455 Views
0 Comments

Conferences
Optimizing Outcomes of TAVR: Role of Imaging
Dr Partho P Sengupta, USA, 06 January 2018
#Cardiology #Cardiology
Ensure patient suitability, selecting device size and contributing to the procedure plan. ...MORE
547 Views
0 Comments

Conferences
Vaccinations in HF can Make a Lot of Difference
Dr Vitull K Gupta, Punjab, 06 January 2018
#Cardiology #Cardiology
Vaccination has proved to be one of the most cost-effective disease prevention strategies. Adult vaccination program in India has been at crossroads and is the ...MORE
621 Views
0 Comments

Conferences
HT During Pregnancy: Mechanisms and Therapeutic Options
Prof Maddury Jyotsna, Hyderabad, 06 January 2018
#Cardiology #Obstetrics and Gynecology
Hypertensive disorders of pregnancy, including pre-eclampsia, complicate up to 10% of pregnancies, constituting one of the greatest causes of maternal and perin ...MORE
504 Views
0 Comments

Conferences
Different Bleeding Scores: A Comparison
Dr U Kaul, New Delhi, 06 January 2018
#Cardiology #Diabetes and Endocrinology
Pharmacological treatment for patients with CVD, especially ACS has considerably improved during the past years. ...MORE
521 Views
0 Comments

Conferences
Which NOAC for which Patient with VTE?
Dr Karthikeyan G, Chennai, 06 January 2018
#Cardiology #Cardiology
Non-vitamin K antagonist oral anticoagulants (NOACs) are better alternatives than traditional anticoagulants in the treatment of venous thromboembolism (VTE). ...MORE
646 Views
0 Comments

Conferences
Recent Advances in Lower Limb Interventions & Peripheral BRS Technology
Dr NN Khanna, New Delhi, 06 January 2018
#Cardiology #Cardiology
The superficial femoral artery (SFA) is a challenging artery to treat. Key developments in SFA intervention range from PTA, atherectomy, stent/stent grafts to d ...MORE
557 Views
0 Comments

Conferences
Cardioprotection in Diabetes: A Changing Landscape
Dr Jamshed J Dalal, Mumbai, 06 January 2018
#Cardiology #Diabetes and Endocrinology
Glycemic control has failed to consistently demonstrate improved macrovascular outcomes. ...MORE
477 Views
0 Comments
Previous Years Coverage